The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 mg Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fed Versus 100 mg of Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fasted Conditions in Healthy Adult Male Subjects

Clinical trial NCT06872866 · RECRUITING

Trial details

NCT number: NCT06872866
Sponsor: Aspargo Labs, Inc
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Erectile Dysfunction

Start date: 2025-04-15
Primary completion: 2026-02-28
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.